Background: Body iron status has been implicated in atherosclerotic cardiovascular disease. The main hypothesis is that high iron status is associated with increased oxidation of LDL. We investigated the potential role of ferritin as an additional risk factor promoting atherosclerosis among a young population with coronary artery disease (CAD). Methods: Four hundred consecutive patients (218 males, 182 females) referred for diagnostic coronary angiography were examined, and risk factors for CAD, lipids, C-reactive protein (CRP), and ferritin concentrations were recorded for all participants. 
The established risk factors of coronary artery disease (CAD) 4 , such as age, male sex, high serum cholesterol, smoking, hypertension, and glucose intolerance, do not account for the overall risk of CAD (1 ) . Therefore, it has been hypothesized that the assessment of novel markers helps to identify persons prone to premature atherosclerosis. Age-and sex-related increases in iron stores have been linked to the pathogenesis of several common diseases, including atherosclerosis (2 ) . Iron stores increase to concentrations above the physiologic requirements with aging, and such increased concentrations have been implicated in the pathogenesis of atherosclerosis. Interest in this hypothesis is stimulated by its capacity to explain the sex difference in atherosclerotic diseases and the option of preventive lowering of iron stores by repeated phlebotomy. Iron catalyzes the formation of reactive oxygen species through the Fenton and Haber-Weiss reactions (3 ) . Free radicals cause lipid peroxidation, leading to the modification of LDL at the molecular level, facilitating its deposition and leading to the formation of atherosclerotic plaque (4 ) .
Divergent information is available on the relationship between body iron stores and CAD. It has been shown that the concentrations of body iron stores are a strong predictor of CAD in eastern Finnish, men (5 ) . Routine voluntary blood donation is associated, epidemiologically, with reduced coronary risk (6, 7 ) . Salonen et al. (8 ) phlebotomized men over age 50 to reduce their body iron stores and demonstrated significantly decreased susceptibility of LDL to ex vivo oxidation. Furthermore, Kiechl et al. (9 ) found a highly significant correlation between Lipids, Lipoproteins, and Cardiovascular Risk Factors serum ferritin concentration and pathologic carotid artery wall thickening in a longitudinal cohort study. However, several epidemiologic studies investigating the association between high body iron stores and risk of cardiovascular disease in humans have not provided positive results (10 -15 ) .
The geographic distribution of CAD incidence over the last 20 years has changed, with a significant decline in industrialized and an increase in developing countries (16 -18 ) . Moreover, the characteristics of coronary risk factors among developing countries also differ in many respects from populations in developed countries (16, 19, 20 ) . However, data regarding the distribution of CAD risk factors among these populations are very scarce in the literature.
To investigate the value of ferritin in coronary risk assessment in a population with a high prevalence of atherosclerosis (21 ), we evaluated the relationship between ferritin and the presence of CAD in the Iranian population.
Materials and Methods subjects
The study population consisted of 218 men and 182 women who were undergoing coronary angiography at Shariaty Hospital of Tehran University of Medical Sciences from June to October 1999. The indications for angiography were suspicion of CAD or preoperative screening for CAD in subjects with valvular disease. All subjects had given written informed consent.
Individuals with a recent history of acute myocardial infarction or percutaneous transluminal coronary angioplasty were not included. Individuals with concomitant inflammatory diseases, cancer, or other diseases possibly associated with an acute-phase reaction, and those who took iron supplements were also excluded. Coronary angiographies were performed according to the standard Judkins technique (22 ) . The patients were classified as CADϩ if one or more coronary arteries had a stenosis Ն50% and as CADϪ if there was no significant stenosis (Յ50%) in any artery. Coronary arteriograms were reviewed by a panel of three cardiologists with no prior knowledge of the clinical history or laboratory data for the patients. Prior medical histories and personal characteristics and habits were obtained from participants via a questionnaire. Hypertension was defined as resting systolic blood pressure Ͼ140 mmHg and diastolic blood pressure Ͼ90 mmHg. The average of the last two of three seated blood pressure readings was used to detect hypertension. Cigarette smoking was defined as ever vs never smoked. Current smoking was defined as smoking cigarettes within the past month. Diabetes was defined as fasting blood glucose Ͼ7.8 mmol/L or a diagnosis of diabetes needing diet or drug therapy.
Blood samples were obtained after a 12-h fast on the day before angiographic procedure and total cholesterol (TC), triglyceride (TG), HDL-cholesterol (HDL-C), ferritin and high-sensitivity C-reactive protein (CRP) concentrations were determined for all patients. Serum samples were separated immediately after collection by centrifugation at 2000g for 15 min and stored at Ϫ80°C until analysis.
laboratory measurements
Cholesterol and TG concentrations were measured enzymatically (Kone Diagnosis) on a Kone specific automated analyzer. HDL-C was determined after precipitation of apolipoprotein B-containing particles by phosphotungstic acid-MgCl 2 . LDL-cholesterol (LDL-C) was estimated using the Friedewald equation (23 ) . Ferritin concentrations were measured with a RIA (Amersham International) using a multigamma Model 1261 gamma counter (LKB Wallac). The between-batch CV was 5.5% and 4.1% for ferritin concentrations of 60 and 180 g/L, respectively (n ϭ 25). Serum CRP concentrations were measured by an ultrasensitive latex-enhanced immunoturbidimetric method (Randox Laboratory Ltd). The detection range for CRP by this method was 0.0 -15 mg/L. The method was standardized against the international reference preparation, CRM 470 (24 ) . The run-to-run imprecision for CRP at concentrations of 1 and 7 mg/L was 4.8% and 3.7%, respectively. All biochemical measurements were carried out without knowledge of the angiographic findings.
statistical analysis
All data are presented as the mean Ϯ SD, with the exception of ferritin, which is presented as the median and 20th-80th percentiles. Statistical analyses were performed with SPSS for Windows, Ver. 10 (SPSS Inc). The Kolmogorov-Smirnov test of normality was used to test whether the distribution of variables followed a gaussian pattern. Because the ferritin frequency distribution was skewed rightward and did not follow a gaussian distribution (P Ͻ0.0001), a natural logarithmic transformation was applied to normalize the data for analysis. The discrete variables were compared by the Pearson 2 test, and the Student t-test was used to compare the continuous variables. The Pearson correlation test was used to assess correlation between the continuous variables. To determine factors independently correlated with CAD, multivariate analysis was carried out by multiple logistic regression analysis using the forward stepwise likelihood ratio method. Adjusted odds ratios (ORs) for the exposure variables and CAD were obtained. All baseline variables related to CAD with a P value Ͻ0.1 in univariate analysis were included in the model. All P values were two-tailed, and values Ͻ0.05 were considered statistically significant. All confidence intervals (CIs) were calculated at the 95% level.
Results
Of the total 400 patients who were examined by angiography, 260 were CADϩ and 140 were free of significant CAD (CADϪ). The indications for angiography in the Clinical Chemistry 47, No. 9, 2001 CADϪ group were suspicion of CAD (85%) or preoperative screening for valvular diseases (15%). In the CADϪ group, 16% had a 25-50% stenosis and 84% had Ͻ25% stenosis or irregularities in the coronary arteries. The indications for angiography in the CADϩ group were suspicion of CAD (99%) or preoperative screening for valvular diseases (1%).
The basic characteristics of study the participants are shown in Table 1 . The analysis in the total population revealed that TC, TG, and ferritin concentrations and the ratio of TC to HDL-C (TC/HDL-C) were higher in the coronary patients, whereas CRP concentrations demonstrated no significant difference between the two groups. The study participants were stratified according to the quartiles of CRP concentrations. There was no significant difference in the percentage of individuals with CRP above the 75th percentiles among CADϪ and CADϩ patients of both genders. Ferritin concentrations were higher in the men relative to the women [109 g/L (range, 45-254 g/L) vs 77 g/L (32-170 g/L), respectively; P Ͻ0.0001]. Ferritin was Ͼ200 g/L in 14% of female participants, whereas 28% of the male participants had ferritin concentrations Ն200 g/L. To adjust the data for the possible effects of confounding factors, the variables were fitted to a multivariate logistic regression model using the stepwise likelihood ratio method. Age (P Ͻ0.0001), sex (P Ͻ0.0001), and TC (P Ͻ0.001) were the only independent discriminating risk factors that showed significant association with CAD in the total population.
Among the women, no significant difference was found between the ferritin concentrations in the CADϩ and CADϪ groups. The postmenopausal women showed higher ferritin relative to the premenopausal women [96 g/L (range, 44 -191 g/L; n ϭ 42) vs 37 g/L (range, 6 -82 g/L; n ϭ 140), respectively; P Ͻ0.0001]. The subgroup analysis for the postmenopausal women revealed no significant difference in the ferritin concentrations of the CADϩ and CADϪ groups. A significant positive correlation was found between age and ferritin concentration in the women (r ϭ 0.391; P Ͻ0.0001).
The univariate analysis for men revealed that ferritin, TC, LDL-C, and TC/HDL-C were greater in the coronary patients relative to CADϪ group. There was no significant difference in the CRP concentrations of the CADϩ and CADϪ groups. When male CADϪ subjects with 25-50% of stenosis (n ϭ 14) were omitted from analysis, a more pronounced difference between the ferritin concentrations of CADϩ and CADϪ individuals was found [CADϩ, 121 g/L (range, 56 -258 g/L; n ϭ 164); CADϪ, 71 g/L (range, 26 -181 g/L; n ϭ 40), respectively; P Ͻ0.001]. The logistic regression model (Table 2) after controlling for age, diabetes, TC, LDL-C, TC/HDL-C, and CRP demonstrated ferritin as an independent determinant of CAD (P Ͻ0.01). The OR for the highest compared with the lowest quartile of ferritin was 1.62 (95% CI, 1.12-2.42; P Ͻ0.01). The subgroup analysis for male patients Յ50 years of age demonstrated a twofold difference in the ferritin concentrations of coronary patients relative to the CADϪ group [137 g/L (range, 75-248 g/L; n ϭ 55) vs 68 g/L (range, 37-154 g/L; n ϭ 24), respectively; P Ͻ0.001]. In this subgroup, the men in the highest quartile of ferritin had an OR of 2.65 (95% CI, 1.35-5.51) compared with the men in the lowest quartile of ferritin (P Ͻ0.003). The male coronary patients Ն50 years of age had higher ferritin concentrations compared with the male individuals Ն50 years of age with no significant CAD [115 g/L (range, 45-269 g/L; n ϭ 109) vs 77 g/L (range, 25-222 g/L; n ϭ 30), respectively; P ϭ 0.049]. However, when the predictors of angiographically significant CAD were assessed using a logistic regression model, the association between ferritin and significant CAD lost its statistical significance in this subgroup (P ϭ 0.289).
The subgroup analysis for the male patients Ն60 years of age revealed no significant differences between the ferritin concentrations of the coronary patients and the CADϪ group [112 g/L (range, 41-245 g/L; n ϭ 79) vs 79 g/L (range, 27-299 g/L; n ϭ 17), respectively; P ϭ 0.384]. Diabetes mellitus was shown to be a potential confounder affecting the relationship between serum ferritin and CAD. Therefore, all logistic regressions were repeated omitting the data from diabetic patients. The omission of these data did not affect the observed association between ferritin and CAD. No significant correlation existed between ferritin and the measured lipid markers, CRP, and age among the male patients.
The ferritin concentrations were higher in the diabetic patients (109 g/L; range, 45-328 g/L; n ϭ 74) in comparison with the nondiabetic individuals (92 g/L; range, 38 -190 g/L; n ϭ 326; P Ͻ0.01). This difference was more pronounced among the male subpopulation [168 g/L (range, 74 -406 g/L; n ϭ 42) vs 106 g/L (range, 44 -221 g/L; n ϭ 176), respectively; P Ͻ0.01]. The median ferritin concentration in the male diabetic patients with CAD (n ϭ 35) tended to be higher relative to the male diabetic patients without CAD (n ϭ 7), but the difference was not
The percentage of individuals in the highest quartile of ferritin was almost twofold higher in the diabetic male patients relative to the nondiabetic male patients (P Ͻ0.003).
Discussion
Our study demonstrated a significant association between serum ferritin and CAD in an Iranian male population with angiographically defined CAD. This association remained significant after adjustment for age, CRP, diabetes, and other coronary risk factors and was more evident in the subgroup of male patients Յ50 years of age.
Ferritin is a high-capacity protein that serves as the body's storage site for iron, and because serum ferritin concentrations are directly proportional to intracellular ferritin concentrations, it is considered the best clinical measure of body iron stores (25 ) . The association between high iron stores and CAD was first suggested by Sullivan (26 ) to explain the sex difference in CAD risk. This hypothesis offers a possible explanation for a wide range of phenomena, including not only the sex difference, but also the protection effects of aspirin, fish oil, and cholestyramine as well as the disease-promoting effect of oral contraceptives (27 ) . Regular daily ingestion of even small doses of aspirin, if continued for months or years, may cause a substantial decrease in iron stores (28 ) . A similar mechanism may explain the effect of fish oil consumption on the incidence of CAD. Moderate fish oil intake is associated with significantly decreased bleeding time (29 ) . Small increases in bleeding time could lead to significant loss of stored iron from occult gastrointestinal blood loss if such increases are sustained. Cholestyramine inhibits the absorption of iron, and its prolonged feeding to rats is associated with a dose-dependent depletion of stored iron (30 ) . It is well known that the use of oral contraceptives diminishes menstrual blood flow and increases stored iron (31 ) .
Epidemiologic studies have found a positive relationship between body iron stores and CAD (5, 9, (32) (33) (34) . Moreover, based on the experimental findings that iron concentrations in the organism are associated with accelerated production of free radicals and increased lipid peroxidation (35, 36 ) , the hypothesis seems plausible. However, several prospective epidemiologic studies found no association between iron stores and CAD (10 -15 ) . The lack of consistency in the epidemiologic studies is probably explained by the large variability in estimates of iron stores and iron intake and by the diversity of study outcomes (2, 37 ) . The ethnic diversity in the manifestations of CAD is another potential factor that merits consideration when interpreting the data relating ferritin and CAD. Large differences in incidence and mortality for CAD between countries have been widely documented (18, 38 ) . At least two hypotheses can be put forward to explain this variability between countries: (a) the incidence of CAD might essentially depend on the prevalence of cardiovascular risk factors in the populations (39, 40 ) , or (b) it might also be determined by the strength of associations between cardiovascular risk factors and CAD in countries (41 ) . Cross-cultural prospective studies have demonstrated that at a cholesterol concentration of ϳ5.43 mmol/L, the CAD mortality rate varies from 5% in Japan to 15% in northern Europe (38 ) . Recently, Rasmussen et al. (42 ) , based on a prospective study, reported that individuals carrying the hemochromatosis gene (HFE) C282Y mutation might be at increased risk of CAD. This report is consistent with previous studies (43, 44 ) and indicates that at least some inconsistency between different prospective studies for ferritin may be attributable to differences in genetic factors among different countries. Early manifestation of CAD is a characteristic that is common among developing countries (16, 19, 45 ) and, according to our clinical experiences, is also frequent in the Iranian population. In the present study, 34% of the male patients with CAD were Յ50 years of age. The association between ferritin and CAD was more pronounced in the male patients Յ50 years than in the men Ն50 years. These data indicate that measurement of ferritin improves the risk assessment of CAD among Iranian men with premature atherosclerosis. Our study demonstrated no significant association between ferritin and CAD in the male patients Ն60 years of age. Aronow (10 ) also reported that serum ferritin is not a risk factor for CAD in men and women Ն62 years of age. The predictive significance of ferritin did not fully extend to elderly populations, possibly because of high rates of interfering diseases and "survival bias" in this subpopulation.
In evaluating the relationship between iron status and the risk of CAD, it is important to rule out non-ironrelated factors that can influence the biochemical measures of iron status. One important factor of this type is inflammation. Serum ferritin increases with inflammation; consequently, the association between serum ferritin and CAD could be confounded by inflammation. This may explain the failure of some previous studies to find an association between ferritin and CAD (46 ) . In the present study, the adjustment for high-sensitivity CRP, a sensitive marker of inflammation, did not affect the results.
The analysis for women revealed no significant association between ferritin and CAD. Further investigations are required to confirm this observation. The lack of association may indicate that a higher ferritin concentration is required to contribute to the progression of atherosclerotic lesions in women. Salonen et al. (5 ) demonstrated that a ferritin concentration Ն200 g/L was associated with a 2.2-fold increase in the risk of acute myocardial infarction in men. This ferritin concentration was observed in only 14% of the female participants, whereas 28% of the men had ferritin concentrations Ն200 g/L. In addition, the effects of other postulated factors associated with the female gender might contribute to the low ferritin concentrations in women. The cardioprotective effect of estrogens in women is well established from epidemiologic and clinical studies (47 ) . The increase in lipid peroxide concentrations in the serum and liver of female mice after ovariectomy provided evidence for antioxidant activities of female hormones. This increase was abolished by the administration of female hormones (48 ) . However, the Heart and Estrogen/Progestin Replacement Study (HERS) trial, a prospective secondary prevention study, did not show a beneficial influence of estrogen replacement therapy on cardiovascular mortality in postmenopausal women (49 ) . This may indicate that alternative treatment strategies for women at coronary risk after menopause need to be evaluated, especially in the light of recent findings of Wassmann et al. (50 ) , which indicate that estrogen deficiency in spontaneously hypertensive rats leads to increased vascular free-radical production via increased vascular angiotensin type 1 receptor overexpression and produces endothelial dysfunction.
The major cause of morbidity and mortality of patients with diabetes is macrovascular disease (51 ) . The mechanisms by which diabetes accelerates atherosclerosis are not well understood. Diabetic patients often have several cardiovascular risk factors, including obesity, high blood pressure, microalbuminuria, and dyslipidemia. However, these risk factors are assumed to account for only ϳ50% of coronary heart disease in diabetic patients (52, 53 ) . Diabetic patients may be exposed to increased oxidative stress. Higher concentrations of lipid peroxides have been detected in the plasma and lipoprotein fractions of diabetic patients (54, 55 ) . LDL isolated from diabetic patients appears to be more susceptible to in vitro oxidation (56, 57 ) . Furthermore, antioxidant mechanisms may also be compromised. A variety of defects in plasma antioxidant status have been described in diabetes, including reduced ascorbate (58 ), urate (59 ), and vitamin E (60 ). Our data indicated that diabetic male patients had higher ferritin concentrations relative to nondiabetic individuals. This finding is consistent with previous studies (61 -63 ) and supports the hypothesis that an imbalance between oxidative stress and antioxidant status exists in diabetic patients.
The potential limitations of this study merit consideration. Our results share the limitations of cross-sectional, observational studies. We evaluated association, not prospective prediction or causation. The study of CAD using CADϪ patients referred for angiography for clinical reasons is attractive because a large difference in the extent of coronary atherosclerosis is identified. However, this design has special limitations. The CADϪ individuals who were referred for angiography because of suspected CAD were likely to have more risk factors and differ in unknown ways from free-living CADϪ populations; for example, contrary to findings of many other studies, CRP, HDL-C, and hypertension are unrelated to CAD in these patients. Therefore, caution should be exercised in interpreting the findings of this study. The definition of CAD patients as having a Ͼ50% obstruction in any coronary artery remains arbitrary. The absence of Ͼ50% stenosis in the coronary arteries does not preclude controls from having atherosclerosis. In spite of having normal angiograms, some individuals in the CADϪ group may have had hemodynamically insignificant atherosclerotic plaques that might be detected by intravascular ultrasound.
These considerations would more likely underestimate than overestimate the strength of ferritin as a risk factor. However, the findings from the current study may be applied to individuals who are referred for angiography, but cannot be extrapolated directly to the general population.
In conclusion, the present study suggests that a high stored iron concentration, as assessed by serum ferritin, is a strong and independent risk factor for premature CAD in the male Iranian population.
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